Determination of low molecular weight heparin in clinical laboratory

Janjaap van Putten; Marjo van de Ruit; Marlene Beunis; H. Coenraad Hemker

doi:10.1159/000215057

Determination of low molecular weight heparin in clinical laboratory

Janjaap van Putten, Marjo van de Ruit, Marlene Beunis, H. Coenraad Hemker

Research output: Contribution to journal › Article › Academic › peer-review

108 Downloads (Pure)

Abstract

The applicability was investigated of automated spectrophotometric heparin assays and three clotting assays for determination of two low molecular weight (LMW) heparin fractions: Org 10172 and DxN10 and two infractionated commercially available heparins. The relative activity of the two commercially available heparins was similar in the anti-Xa assay, in the anti-IIa assay and in 3 clotting assays. The LMW heparins showed markedly different relative activity in all 5 assays. The activities of those heparin preparations relative to the standard heparin were compared in the 5 assays, but standardization against a standard heparin preparation appeared impossible. Methods of heparin determination can be used to monitor treatment with a heparin preparation only if the same preparation is used as a reference substance.

Original language	English
Pages (from-to)	205-210
Number of pages	6
Journal	Haemostasis
Volume	14
Issue number	2
DOIs	https://doi.org/10.1159/000215057
Publication status	Published - 1984

Access to Document

10.1159/000215057

Full TextFinal published version, 5.89 MB

Cite this

@article{971c22e3076740e59483525200325be6,

title = "Determination of low molecular weight heparin in clinical laboratory",

abstract = "The applicability was investigated of automated spectrophotometric heparin assays and three clotting assays for determination of two low molecular weight (LMW) heparin fractions: Org 10172 and DxN10 and two infractionated commercially available heparins. The relative activity of the two commercially available heparins was similar in the anti-Xa assay, in the anti-IIa assay and in 3 clotting assays. The LMW heparins showed markedly different relative activity in all 5 assays. The activities of those heparin preparations relative to the standard heparin were compared in the 5 assays, but standardization against a standard heparin preparation appeared impossible. Methods of heparin determination can be used to monitor treatment with a heparin preparation only if the same preparation is used as a reference substance.",

author = "{van Putten}, Janjaap and {van de Ruit}, Marjo and Marlene Beunis and Hemker, {H. Coenraad}",

year = "1984",

doi = "10.1159/000215057",

language = "English",

volume = "14",

pages = "205--210",

journal = "Haemostasis",

issn = "0301-0147",

publisher = "S. Karger AG",

number = "2",

}

TY - JOUR

T1 - Determination of low molecular weight heparin in clinical laboratory

AU - van Putten, Janjaap

AU - van de Ruit, Marjo

AU - Beunis, Marlene

AU - Hemker, H. Coenraad

PY - 1984

Y1 - 1984

N2 - The applicability was investigated of automated spectrophotometric heparin assays and three clotting assays for determination of two low molecular weight (LMW) heparin fractions: Org 10172 and DxN10 and two infractionated commercially available heparins. The relative activity of the two commercially available heparins was similar in the anti-Xa assay, in the anti-IIa assay and in 3 clotting assays. The LMW heparins showed markedly different relative activity in all 5 assays. The activities of those heparin preparations relative to the standard heparin were compared in the 5 assays, but standardization against a standard heparin preparation appeared impossible. Methods of heparin determination can be used to monitor treatment with a heparin preparation only if the same preparation is used as a reference substance.

AB - The applicability was investigated of automated spectrophotometric heparin assays and three clotting assays for determination of two low molecular weight (LMW) heparin fractions: Org 10172 and DxN10 and two infractionated commercially available heparins. The relative activity of the two commercially available heparins was similar in the anti-Xa assay, in the anti-IIa assay and in 3 clotting assays. The LMW heparins showed markedly different relative activity in all 5 assays. The activities of those heparin preparations relative to the standard heparin were compared in the 5 assays, but standardization against a standard heparin preparation appeared impossible. Methods of heparin determination can be used to monitor treatment with a heparin preparation only if the same preparation is used as a reference substance.

U2 - 10.1159/000215057

DO - 10.1159/000215057

M3 - Article

SN - 0301-0147

VL - 14

SP - 205

EP - 210

JO - Haemostasis

JF - Haemostasis

IS - 2

ER -